NPPA fixed retail price of 51 formulations: June 2023

Last Updated on January 6, 2024 by The Health Master

Download NPPA notification No. S.O. S.O. 2821(E) dt 28-06-2023, the link is given below: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 51 formulations under the Drugs (Prices Control) Order, 2013, vide S.O. 2821(E) dt 28-06-2023 based on the decision of the 114th Authority meeting dated 19-06-2023.

This price fixation followed the decision of the 114th Authority meeting on June 19, 2023

The notification states as under:

In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

Table is given below the article

Note:
(a) The manufacturer of the above-mentioned formulations, i.e., the “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013.

The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e.. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules,
including manufacturing license permission from the competent authority, i.e., the central or state licensing authority, as may be applicable, by the concerned manufacturer/marketing company.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per the instant price notification and notes specified hereinabove, then the concerned manufacturer / marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing
Companies as specified in corresponding entries in Columns (2), (3), and (5) thereof, if any, issued prior to this notification, stand superseded.

Table

Sl. No.	Name of the Formulation / Brand Name	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1	Ciprofloxacin & Dexamethasone Eye Drops	Composition: Ciprofloxacin Hydrochloride IP eq. to Ciprofloxacin 0.3% w/v Dexamethasone IP 0.1% w/v Benzalkonium Chlorid Sodium IP 0.02% v/v (As preservative) Sterile aqueous Vehicle q.s.	1 ml	M/s Skymap Healthcare Pvt. Ltd. /M/s Healing Pharma India Pvt. Ltd.	2.05
2	Paracetamol, Phenylephrine and Chlorphenirami ne Drops	Each ml (approximately 30 drops) contains: Paracetamol IP 125mg Phenylephrine Hydrochloride IP 2.5mg Chlorpheniramine Maleate IP 1.0mg	1 ml	M/s Cris Pharma (I) Ltd.. / M/s Mankind Prime Labs Pvt. Ltd.	4.15
3	Paroxetine Controlled release & Clonazepam Capsules	Each hard gelatine capsule contains: Paroxetine Hydrochloride IP eq. to Paroxetine 25mg (As enteric coated controlled release tablet) &Clonazepam IP 0.5mg (as immediate release tablet)	1 Capsule	M/s Akums Drugs & Pharmaceuticals Limited / M/s Eris Lifesciences Limited	15.81
4	Etoricoxib and Paracetamol Tablets	Each Film Coated tablet contains: Etoricoxib IP 60 mg Paracetamol IP 325 mg	1 Tablet	M/s Pfizer Limited	8.99
5	Linagliptin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Linagliptin IP 2.5mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Intas Pharmaceuticals Ltd.	8.97
6	Linagliptin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Linagliptin IP 2.5mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Intas Pharmaceuticals Ltd.	9.60
7	Linagliptin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Linagliptin IP 2.5mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Torrent Pharmaceuticals Ltd.	8.90
8	Linagliptin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Linagliptin IP 2.5mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Torrent Pharmaceuticals Ltd.	9.50

9	Linagliptin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Linagliptin IP 2.5mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Unison Pharmaceuticals Pvt. Ltd.	8.97
10	Linagliptin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Linagliptin IP 2.5mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Unison Pharmaceuticals Pvt. Ltd.	9.60
11	Dapagliflozin, Sitagliptin and Metformin Hydrochloride (as Extended Release) Tablets	Each film coated tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 100mg Metformin Hydrochloride IP 500mg (as Extended Release)	1 Tablet	M/s Exemed Pharmaceuticals / M/s Wockhardt Limited	16.95
12	Dapagliflozin, Sitagliptin and Metformin Hydrochloride (as Extended Release) Tablets	Each film coated tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 100mg Metformin Hydrochloride IP 1000mg (as Extended Release)	1 Tablet	M/s Exemed Pharmaceuticals / M/s Wockhardt Limited	17.84
13	Dapagliflozin, Sitagliptin and Metformin Hydrochloride (ER) Tablets	Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 100mg Metformin Hydrochloride IP 500mg (As an Extended- release form)	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.	19.57
14	Dapagliflozin, Sitagliptin and Metformin Hydrochloride (ER) Tablets	Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 100mg Metformin Hydrochloride IP 1000mg (As an Extended release form)	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Aristo Pharmaceuticals Pvt. Ltd.	20.67

15	Dapagliflozin, Sitagliptin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Sun Pharma Laboratories Limited	13.63
16	Dapagliflozin, Sitagliptin and Metformin Hydrochloride Tablets	Each film coated tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Sitagliptin Phosphate Monohydrate eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Sun Pharma Laboratories Limited	14.60
17	Dapagliflozin, Vildagliptin (SR) and Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 500mg (as Sustained Release)	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Alkem Laboratories Ltd.	18.76
18	Dapagliflozin, Vildagliptin (SR) and Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 1000mg (as Sustained Release)	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Alkem Laboratories Ltd.	19.87
19	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Vildagliptin IP (As Sustained release) 100mg Metformin Hydrochloride IP 500mg (as Sustained Release)	1 Tablet	M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Limited	16.18
20	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Vildagliptin IP (As Sustained release) 100mg Metformin Hydrochloride IP 1000mg (as Sustained Release)	1 Tablet	M/s Exemed Pharmaceuticals / M/s Eris Lifesciences Limited	17.04

21	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Vildagliptin (As Sustained release) IP  100mg Metformin Hydrochloride (as Sustained Release) IP 500mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Emcure Pharmaceuticals Limited	16.18
22	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Vildagliptin (As Sustained release) IP  100mg Metformin Hydrochloride (as Sustained Release) IP 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Emcure Pharmaceuticals Limited	17.04
23	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin (As Sustained release) IP 100mg Metformin Hydrochloride (as Sustained Release) IP 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Mankind Pharma Ltd.	20.11
24	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin (As Sustained release)  IP 100mg Metformin Hydrochloride (as Sustained Release)  IP 500mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Mankind Pharma Ltd.	19.00
25	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Vildagliptin (As Sustained release)  IP 100mg Metformin Hydrochloride (as Sustained Release) IP 500mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Intas Pharmaceuticals Ltd.	12.50
26	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Vildagliptin (As Sustained release)  IP 100mg Metformin Hydrochloride (as Sustained Release) IP 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Intas Pharmaceuticals Ltd.	15.00

27	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Vildagliptin (As Sustained release)  IP 100mg Metformin Hydrochloride (as Sustained Release) IP 500mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Zydus Healthcare Limited	16.04
28	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 5mg Vildagliptin (As Sustained release)  IP 100mg Metformin Hydrochloride (as Sustained Release) IP 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Zydus Healthcare Limited	16.98
29	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin (As Sustained release)  IP 100mg Metformin Hydrochloride (as Sustained Release)  IP 500mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Alembic Pharmaceuticals Limited	19.11
30	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin (As Sustained release) IP 100mg Metformin Hydrochloride (as Sustained Release) IP 500mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Unison Pharmaceuticals Pvt. Ltd.	14.90
31	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each film coated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin (As Sustained release) IP  100mg Metformin Hydrochloride (as Sustained Release) IP 1000mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Unison Pharmaceuticals Pvt. Ltd.	16.44
32	Dapagliflozin, Vildagliptin (SR) and Metformin Hydrochloride (SR) Tablets	Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 500mg (as Sustained Release)	1 Tablet	M/s Exemed Pharmaceuticals / M/s Torrent Pharmaceuticals Limited	19.00

33	Dapagliflozin, Vildagliptin (SR) and Metformin Hydrochloride (SR) Tablets	Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 1000mg (as Sustained Release)	1 Tablet	M/s Exemed Pharmaceuticals / M/s Torrent Pharmaceuticals Limited	20.11
34	Dapagliflozin, Vildagliptin (As Sustained release) and Metformin Hydrochloride (as Sustained Release) Tablets	Each uncoated bilayered tablet contains: Dapagliflozin Propanediol Monohydrate eq. to Dapagliflozin 10mg Vildagliptin (As Sustained release)  IP 100mg Metformin Hydrochloride (as Sustained Release)  IP 500mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Alembic Pharmaceuticals Limited	19.11
35	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each uncoated bilayered tablet  contains: Sitagliptin Phosphate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500mg (Sustained Release Form)	1 Tablet	M/s Alkem Health Science (A Unit of Alkem Laboratories Ltd.) / M/s Alkem Laboratories Ltd	16.33
36	Sitagliptin, Pioglitazone and Metformin Hydrochloride (Sustained Released) Tablet	Each uncoated bilayered tablet  contains: Sitagliptin Phosphate IP eq. to Sitagliptin 100mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 1000mg (Sustained Release Form)	1 Tablet	M/s Alkem Health Science (A Unit of Alkem Laboratories Ltd.) / M/s Alkem Laboratories Ltd	17.69
37	Vildagliptin (SR) & Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Vildagliptin IP (As Sustained Release) 100mg Metformin Hydrochloride IP (As Sustained Release) 500mg	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Intas Pharmaceuticals Ltd.	12.11
38	Vildagliptin (SR) & Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Vildagliptin IP (As Sustained Release) 100mg Metformin Hydrochloride IP (As Sustained Release) 500mg	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd.	12.11
39	Vildagliptin (SR) and Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 500mg (as Sustained Release)	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Zydus Healthcare Limited	12.28

40	Vildagliptin (SR) and Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 500mg (as Sustained Release)	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Lupin Limited	12.28
41	Vildagliptin (SR) and Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 500mg (as Sustained Release)	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Eris Lifesciences Limited	12.28
42	Vildagliptin (SR) and Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 500mg (as Sustained Release)	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Cipla Limited	12.28
43	Vildagliptin (SR) & Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Vildagliptin IP (As Sustained Release) 100mg Metformin Hydrochloride IP (As Sustained Release) 1000mg	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Intas Pharmaceuticals Ltd.	13.65
44	Vildagliptin (SR) & Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Vildagliptin IP (As Sustained Release) 100mg Metformin Hydrochloride IP (As Sustained Release) 1000mg	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Ltd.	13.65
45	Vildagliptin (SR) and Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 1000mg (as Sustained Release)	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Lupin Limited	13.82
46	Vildagliptin (SR) and Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 1000mg (as Sustained Release)	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Zydus Healthcare Limited	13.82
47	Vildagliptin (SR) and Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 1000mg (as Sustained Release)	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Eris Lifesciences Limited	13.82

48	Vildagliptin (SR) and Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 1000mg (as Sustained Release)	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Cipla Limited	13.82
49	Vildagliptin (SR) and Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 500mg (as Sustained Release)	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Mankind Pharma Ltd.	12.14
50	Vildagliptin (SR) and Metformin Hydrochloride (SR) Tablets	Each film coated bilayered tablet contains: Vildagliptin IP 100mg (As Sustained Release) Metformin Hydrochloride IP 1000mg (as Sustained Release)	1 Tablet	M/s Synokem Pharmaceuticals Ltd. / M/s Mankind Pharma Ltd.	13.68
51	Zinc Sulfate Monohydrate, Sodium Citrate, Potassium Chloride, Sodium Chloride, Dextrose Anhydrous Sachet	Each 4.4g sachet contains: Zinc Sulfate Monohydrate IP 0.011g Sodium Citrate IP 0.58g Potassium Chloride IP 0.30g Sodium Chloride IP 0.52g Dextrose Anhydrous IP 2.70g	Per Sachet of 4.4 gm	M/s Acme Diet Care Pvt. Ltd. / M/s RPG Life Sciences Ltd.	6.12

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos by The Health Master, click on the below YouTube icon:

• Key Notes on Revised Schedule M: Point No. 14 – Materials
  December 25, 2024
• USFDA issues VAI status to Biocon for Bengaluru API facility
  December 25, 2024
• Bulk drug import from China continues to rise in 5 years
  December 25, 2024
• High Court stays action against Pharma Units manufacturing Nutraceuticals
  December 25, 2024
• NPPA fixed retail price of 7 formulations: December 2024
  December 24, 2024
• Revised Schedule M: Industry seeks balance between Quality and Viability
  December 24, 2024

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on consumer awareness, click on the below YouTube icon: